Home > Publications Database > CEST‐2.2 overexpression alters lipid metabolism and extends longevity of mitochondrial mutants > print |
001 | 163786 | ||
005 | 20240320115522.0 | ||
024 | 7 | _ | |a pmc:PMC9066074 |2 pmc |
024 | 7 | _ | |a 10.15252/embr.202152606 |2 doi |
024 | 7 | _ | |a 1469-221X |2 ISSN |
024 | 7 | _ | |a 1469-3178 |2 ISSN |
024 | 7 | _ | |a altmetric:124915389 |2 altmetric |
024 | 7 | _ | |a pmid:35297148 |2 pmid |
037 | _ | _ | |a DZNE-2022-00524 |
082 | _ | _ | |a 570 |
100 | 1 | _ | |a Piazzesi, Antonia |0 P:(DE-2719)2811171 |b 0 |e First author |
245 | _ | _ | |a CEST‐2.2 overexpression alters lipid metabolism and extends longevity of mitochondrial mutants |
260 | _ | _ | |a Hoboken, NJ [u.a.] |c 2022 |b Wiley |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1654089378_17981 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Mitochondrial dysfunction can either extend or decrease Caenorhabditis elegans lifespan, depending on whether transcriptionally regulated responses can elicit durable stress adaptation to otherwise detrimental lesions. Here, we test the hypothesis that enhanced metabolic flexibility is sufficient to circumvent bioenergetic abnormalities associated with the phenotypic threshold effect, thereby transforming short-lived mitochondrial mutants into long-lived ones. We find that CEST-2.2, a carboxylesterase mainly localizes in the intestine, may stimulate the survival of mitochondrial deficient animals. We report that genetic manipulation of cest-2.2 expression has a minor lifespan impact on wild-type nematodes, whereas its overexpression markedly extends the lifespan of complex I-deficient gas-1(fc21) mutants. We profile the transcriptome and lipidome of cest-2.2 overexpressing animals and show that CEST-2.2 stimulates lipid metabolism and fatty acid beta-oxidation, thereby enhancing mitochondrial respiratory capacity through complex II and LET-721/ETFDH, despite the inherited genetic lesion of complex I. Together, our findings unveil a metabolic pathway that, through the tissue-specific mobilization of lipid deposits, may influence the longevity of mitochondrial mutant C. elegans. |
536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 0 |
536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 1 |
536 | _ | _ | |a 354 - Disease Prevention and Healthy Aging (POF4-354) |0 G:(DE-HGF)POF4-354 |c POF4-354 |f POF IV |x 2 |
588 | _ | _ | |a Dataset connected to CrossRef, Journals: pub.dzne.de |
650 | _ | 2 | |a Animals |2 MeSH |
650 | _ | 2 | |a Caenorhabditis elegans: metabolism |2 MeSH |
650 | _ | 2 | |a Caenorhabditis elegans Proteins: genetics |2 MeSH |
650 | _ | 2 | |a Caenorhabditis elegans Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a Lipid Metabolism: genetics |2 MeSH |
650 | _ | 2 | |a Longevity: genetics |2 MeSH |
650 | _ | 2 | |a Mitochondria: metabolism |2 MeSH |
700 | 1 | _ | |a Wang, Yiru |0 P:(DE-2719)9001250 |b 1 |
700 | 1 | _ | |a Jackson, Joshua |0 P:(DE-2719)2814190 |b 2 |
700 | 1 | _ | |a Wischhof, Lena |0 P:(DE-2719)2811527 |b 3 |
700 | 1 | _ | |a Zeisler-Diehl, Viktoria |b 4 |
700 | 1 | _ | |a Scifo, Enzo |0 P:(DE-2719)2812562 |b 5 |
700 | 1 | _ | |a Oganezova, Ina |0 P:(DE-2719)9001607 |b 6 |
700 | 1 | _ | |a Hoffmann, Nils Thorben |0 P:(DE-2719)2813300 |b 7 |
700 | 1 | _ | |a Gomez, Pablo |0 P:(DE-2719)9002156 |b 8 |u dzne |
700 | 1 | _ | |a Bertan, Fabio |0 P:(DE-2719)2810664 |b 9 |
700 | 1 | _ | |a Wrobel, Chester J J |b 10 |
700 | 1 | _ | |a Schroeder, Frank C |b 11 |
700 | 1 | _ | |a Ehninger, Dan |0 P:(DE-2719)2289209 |b 12 |
700 | 1 | _ | |a Händler, Kristian |0 P:(DE-2719)2812735 |b 13 |
700 | 1 | _ | |a Schultze, Joachim L |0 P:(DE-2719)2811660 |b 14 |
700 | 1 | _ | |a Schreiber, Lukas |0 0000-0001-7003-9929 |b 15 |
700 | 1 | _ | |a Echten-Deckert, Gerhild |0 0000-0002-2816-7852 |b 16 |
700 | 1 | _ | |a Nicotera, Pierluigi |0 P:(DE-2719)2010732 |b 17 |
700 | 1 | _ | |a Bano, Daniele |0 P:(DE-2719)2158358 |b 18 |e Last author |
773 | _ | _ | |a 10.15252/embr.202152606 |0 PERI:(DE-600)2025376-X |n 5 |p e52606 |t EMBO reports |v 23 |y 2022 |x 1469-221X |
856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/163786/files/EMBO%20Reports%20-%202022%20-%20Piazzesi%20-%20CEST%E2%80%902%202%20overexpression%20alters%20lipid%20metabolism%20and%20extends%20longevity%20of%20mitochondrial.pdf |
856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/163786/files/EMBO%20Reports%20-%202022%20-%20Piazzesi%20-%20CEST%E2%80%902%202%20overexpression%20alters%20lipid%20metabolism%20and%20extends%20longevity%20of%20mitochondrial.pdf?subformat=pdfa |
909 | C | O | |o oai:pub.dzne.de:163786 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 0 |6 P:(DE-2719)2811171 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)9001250 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2814190 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2811527 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2812562 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)9001607 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2813300 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)9002156 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)2810664 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 12 |6 P:(DE-2719)2289209 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2812735 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2811660 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 17 |6 P:(DE-2719)2010732 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 18 |6 P:(DE-2719)2158358 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 0 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 1 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-354 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Prevention and Healthy Aging |x 2 |
914 | 1 | _ | |y 2022 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-09 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-09 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-09 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-02-03 |
915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EMBO REP : 2021 |d 2022-11-09 |
915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2021-02-03 |w ger |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-03 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-09 |
915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-09 |
915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EMBO REP : 2021 |d 2022-11-09 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-03 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-09 |
920 | 1 | _ | |0 I:(DE-2719)1013003 |k AG Bano |l Aging and neurodegeneration |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1013005 |k AG Ehninger |l Translational Biogerontology |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1013031 |k AG Schultze |l United epigenomic platform |x 2 |
920 | 1 | _ | |0 I:(DE-2719)5000031 |k R&D PRECISE |l Platform for Single Cell Genomics and Epigenomics at DZNE & University of Bonn |x 3 |
920 | 1 | _ | |0 I:(DE-2719)1030000 |k Scientific board |l Scientific board |x 4 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a UNRESTRICTED |
980 | _ | _ | |a I:(DE-2719)1013003 |
980 | _ | _ | |a I:(DE-2719)1013005 |
980 | _ | _ | |a I:(DE-2719)1013031 |
980 | _ | _ | |a I:(DE-2719)5000031 |
980 | _ | _ | |a I:(DE-2719)1030000 |
980 | 1 | _ | |a FullTexts |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|